Regal Healthcare Capital Partners Closes Oversubscribed Fund IV at $610 Million

NEW YORK – Regal Healthcare Capital Partners, a private equity firm focused on the healthcare services sector, announced on July 7, 2026, the final closing of its fourth fund, RHCP IV, with total commitments of $610 million. The fund significantly surpassed its original target of $550 million, signaling strong investor confidence in the firm’s strategy amid a competitive fundraising environment.

The successful fundraise brings Regal’s total aggregate commitments to nearly $1.3 billion since the firm was established in 2018. According to a company announcement, Fund IV secured approximately $575 million in external commitments. The firm noted robust support from its existing limited partners while also attracting a diverse group of new blue-chip investors, including prominent endowments, foundations, asset managers, consultants, and public pension plans, thereby expanding its investor base both by geography and institution type.

This latest fund marks a significant step up in scale for the New York-based firm. Its predecessor, RHCP III, closed in 2021 with $415 million in capital commitments, which itself had exceeded a $325 million target. The nearly 50% increase in fund size from Fund III to Fund IV underscores a period of rapid growth and a consistent track record of exceeding fundraising goals. Regal’s first two funds were raised in February 2018 and July 2019, establishing a capital base that exceeded $665 million after the close of its third fund.

Regal’s investment thesis remains narrowly focused on partnering with entrepreneurs and management teams within U.S. healthcare services companies. The firm typically targets businesses with revenues between $20 million and $100 million, making equity investments that range from $20 million to $70 million per transaction. The fresh $610 million in capital is expected to be deployed into a variety of middle-market healthcare service providers, providing growth capital and strategic support to help scale operations.

The closing of Fund IV injects significant new capital into the healthcare services ecosystem, an area ripe for consolidation and innovation. For small and mid-sized businesses in sectors such as physician practice management, outpatient services, and specialized care clinics, the fund represents a substantial new source of potential partnership and exit opportunities. The oversubscription of the fund suggests that institutional investors continue to see long-term value and resilience in the non-cyclical nature of healthcare services, even as the broader economy faces uncertainty.

In a statement, Regal’s General Partners commented on the successful close. “The quality and diversity of our Fund IV investor base speaks for itself, and we are deeply grateful to our longstanding partners and new investors alike for the trust they have placed in us,” said David Kim, MD. His partner, Jon Santemma, added, “Fund IV reflects the confidence our investors have placed in our team and strategy, and we are excited about the opportunities ahead.”

The firm utilized Lazard as the exclusive placement agent for the fundraising effort, while Kirkland & Ellis served as its legal counsel. These partnerships are common for institutional-grade fundraises and reflect the complexity and scale of securing commitments from a global investor base.

For entrepreneurs in the healthcare services space, the announcement of a new, well-funded player actively seeking investment targets is a significant development. Our experience shows that while a large fund like this creates opportunity, it also raises the bar for what it takes to be an attractive candidate for investment. Private equity firms conduct exhaustive due diligence, and companies that are not prepared with institutional-quality financial reporting, clear growth strategies, and a compelling investor narrative are often passed over, regardless of their operational success. Many business owners underestimate the sheer amount of preparation required to navigate the capital raising process successfully. This involves building a robust data room, developing defensible financial projections, and articulating a strategic vision that aligns with a PE partner’s objectives. The firm’s capital raising and investor strategy services are specifically designed to bridge this gap. We work with clients to professionalize their financial and strategic posture long before they ever speak to an investor. For business owners looking to capitalize on this wave of investment, engaging with the advisory team at C&S Finance Group LLC at csfinancegroup.com can be a critical first step in positioning their company for a successful transaction.

Looking ahead, market participants will be closely watching for Regal’s initial platform investments from Fund IV. The specific sub-sectors and business models the firm targets will provide valuable insight into where sophisticated capital sees the most promising growth trajectories within the dynamic U.S. healthcare services landscape. These early deals will set the tone for the fund’s deployment cycle and serve as a bellwether for M&A activity in the sector for the coming years.